MKS Instruments (MKSI) Raised to Buy at Zacks Investment Research

Zacks Investment Research upgraded shares of MKS Instruments (NASDAQ:MKSI) from a hold rating to a buy rating in a research report report published on Friday. They currently have $127.00 target price on the scientific and technical instruments company’s stock.

According to Zacks, “MKS Instruments’ shares have outperformed the industry in the past year. The company is benefiting from stronger semiconductor business, Newport Corporation buyout, sturdy demand for innovative products and superior customer relationships. These are expected to drive near-term results. Estimates have been stable lately ahead of the company's Q1 earnings release. However, intense competition in the industry is a major headwind. Loss of demand from a prominent buyer or a sudden supply chain challenge remains concerns. The company has mixed record of earnings surprises in recent quarters.”

How to Become a New Pot Stock Millionaire

A number of other brokerages have also weighed in on MKSI. KeyCorp reaffirmed a buy rating on shares of MKS Instruments in a research note on Friday, February 2nd. Stifel Nicolaus reaffirmed a buy rating and issued a $133.00 price target on shares of MKS Instruments in a research note on Thursday, February 1st. Dougherty & Co reaffirmed a buy rating on shares of MKS Instruments in a research note on Sunday, February 4th. ValuEngine raised shares of MKS Instruments from a hold rating to a buy rating in a research note on Friday, February 2nd. Finally, BidaskClub raised shares of MKS Instruments from a hold rating to a buy rating in a research note on Saturday, January 20th. Six equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. MKS Instruments currently has an average rating of Buy and a consensus price target of $123.00.

Shares of NASDAQ:MKSI opened at $110.40 on Friday. The company has a market capitalization of $6,015.56, a PE ratio of 18.56, a P/E/G ratio of 1.05 and a beta of 0.92. MKS Instruments has a twelve month low of $64.75 and a twelve month high of $128.28. The company has a quick ratio of 3.10, a current ratio of 4.27 and a debt-to-equity ratio of 0.25.

MKS Instruments (NASDAQ:MKSI) last issued its quarterly earnings results on Wednesday, January 31st. The scientific and technical instruments company reported $1.71 earnings per share for the quarter, topping analysts’ consensus estimates of $1.63 by $0.08. The company had revenue of $512.00 million during the quarter, compared to analyst estimates of $500.22 million. MKS Instruments had a net margin of 17.70% and a return on equity of 22.51%. The business’s revenue for the quarter was up 26.4% compared to the same quarter last year. During the same period in the prior year, the business posted $1.05 EPS. equities analysts forecast that MKS Instruments will post 7.89 earnings per share for the current year.

In related news, Director Elizabeth Mora sold 300 shares of the business’s stock in a transaction that occurred on Thursday, March 1st. The shares were sold at an average price of $111.10, for a total value of $33,330.00. Following the sale, the director now directly owns 15,554 shares in the company, valued at approximately $1,728,049.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Peter Hanley sold 430 shares of the business’s stock in a transaction that occurred on Wednesday, March 14th. The stock was sold at an average price of $123.40, for a total transaction of $53,062.00. Following the completion of the sale, the director now owns 1,992 shares in the company, valued at $245,812.80. The disclosure for this sale can be found here. Insiders sold a total of 41,443 shares of company stock worth $4,566,392 over the last quarter. Insiders own 1.67% of the company’s stock.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Meeder Asset Management Inc. raised its holdings in shares of MKS Instruments by 311.2% in the 4th quarter. Meeder Asset Management Inc. now owns 1,065 shares of the scientific and technical instruments company’s stock worth $101,000 after purchasing an additional 806 shares in the last quarter. Krilogy Financial LLC bought a new stake in shares of MKS Instruments in the 3rd quarter worth approximately $144,000. Advisor Partners LLC bought a new stake in shares of MKS Instruments in the 4th quarter worth approximately $206,000. Zeke Capital Advisors LLC bought a new stake in shares of MKS Instruments in the 4th quarter worth approximately $220,000. Finally, Csenge Advisory Group bought a new stake in shares of MKS Instruments in the 4th quarter worth approximately $226,000. Institutional investors and hedge funds own 93.92% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The correct version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/04/09/mks-instruments-mksi-raised-to-buy-at-zacks-investment-research.html.

MKS Instruments Company Profile

MKS Instruments, Inc is a global provider of instruments, subsystems and process control solutions that measures, controls, powers, delivers, monitors and analyzes critical parameters of advanced manufacturing processes. The Company operates through two segments, including the Vacuum & Analysis segment and the Light & Motion segment.

Get a free copy of the Zacks research report on MKS Instruments (MKSI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for MKS Instruments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MKS Instruments and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply